You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ELVN Sale Disclosure
Kunkel Lori Anne · SEC Form 4 · Filed Jul 8, 2026
Sale
Calculated transaction value
$205.48K
Kunkel Lori Anne Director
ELVN
Enliven Therapeutics
ELVN
Transaction date
Jul 6, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 2 days later
ELVN daily price context
Close on/before transaction
$50.01
Jul 6, 2026
First close after public filing
$52.18
Jul 9, 2026
30-day return after filing
+15.87%
Through Aug 7, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,111 shares @ $49.98
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001536368-26-000007
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$504.9K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN Current | Sale | Jul 6, 2026 | $205.48K |
| Enliven Therapeutics, Inc. ELVN | Sale | Jul 6, 2026 | $299.42K |